A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Exscientia AI Limited
Baylor College of Medicine
Baylor College of Medicine
Duke University
Pilatus Biosciences Inc
Essen Biotech
Essen Biotech
Seattle Children's Hospital
Angiex, Inc.
Takeda
Baylor College of Medicine
Second Life Therapeutics
UNC Lineberger Comprehensive Cancer Center
RenJi Hospital
University Health Network, Toronto
Coherus Oncology, Inc.
UNC Lineberger Comprehensive Cancer Center
MacroGenics
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Brigham and Women's Hospital
Novita Pharmaceuticals, Inc.
ModeX Therapeutics, An OPKO Health Company
Celldex Therapeutics
Columbia University
Icahn School of Medicine at Mount Sinai
Centre Georges Francois Leclerc
Universidade Federal de Pernambuco
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
VA Office of Research and Development
Xencor, Inc.
Pfizer
Washington University School of Medicine
Konkuk University Medical Center
Sun Yat-sen University
Pfizer
Celldex Therapeutics
Zhejiang University
Fusion Pharmaceuticals Inc.
Children's Oncology Group
Massachusetts General Hospital
Klus Pharma Inc.
City of Hope Medical Center
Celldex Therapeutics
Xencor, Inc.
Bristol-Myers Squibb
Quadriga Biosciences, Inc.
Xencor, Inc.
Pfizer